Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin

被引：0
|
作者：
E McDonald
F Landry
C Rabbat
C Boudreau
M Crowther
M Meade
W Geerts
D Cook
机构：
[1] McMaster University,
[2] University of Toronto,undefined
来源：
Critical Care | / 7卷 / Suppl 2期
关键词：
Molecular Weight; Creatinine; Renal Function; Heparin; Emergency Medicine;
D O I：
10.1186/cc2001
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Relationship between trough anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin
    McDonald, E
    Landry, F
    Boudreau, C
    Rabbat, C
    Crowther, M
    Meade, M
    Guyatt, G
    Cook, DJ
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (12) : A154 - A154
  • [2] Monitoring of Anti-Xa in Pregnant Patients with Mechanical Prosthetic Valves Receiving Low Molecular Weight Heparin: Peak or Trough Levels?
    John, Fan
    Goland, Sorel
    Khatri, Nudrat
    Elkayam, Uri
    [J]. CIRCULATION, 2010, 122 (21)
  • [3] Use of therapeutic dose low molecular weight heparin in patients with renal insufficiency: Analysis of anti-Xa levels and creatinine clearance.
    Lim, Wendy
    Sridhara, Manasa
    Wang, Luqi
    Kinnon, Krystyna
    Douketis, James
    Crowther, Mark
    [J]. BLOOD, 2006, 108 (11) : 265A - 265A
  • [4] Monitoring of Anti-Xa in Pregnant Patients With Mechanical Prosthetic Valves Receiving Low-Molecular-Weight Heparin: Peak or Trough Levels?
    Goland, Sorel
    Schwartzenberg, Shmuel
    Fan, John
    Kozak, Natasha
    Khatri, Nudrat
    Elkayam, Uri
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (05) : 451 - 456
  • [5] Calculated creatinine clearance in ICU patients receiving low molecular weight heparin: An inter-rater reliability study
    Cook, DJ
    McDonald, E
    Landry, F
    Bourdreau, C
    Rabbat, C
    Crowther, M
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (12) : A154 - A154
  • [6] THE LACK OF RELATIONSHIP BETWEEN ANTI-XA ACTIVITY AND ANTITHROMBOTIC ACTIVITY OF LOW-MOLECULAR WEIGHT HEPARIN
    OCKELFORD, PA
    CARTER, CJ
    HIRSH, J
    [J]. THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 116 - 116
  • [7] ANTI-XA POTENTIATING EFFECT OF LOW-MOLECULAR WEIGHT HEPARIN
    JUNKER, W
    HARENBERG, J
    FUSSI, F
    MATTES, K
    ZIMMERMANN, R
    WEBER, E
    [J]. THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 235 - 235
  • [8] Anti-Xa monitoring of low-molecular-weight heparin in adult patients with cancer
    Kreuziger, Lisa Baumann
    Streiff, Michael
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 206 - 207
  • [9] Low molecular weight heparin is responsible for the anti-Xa activity of desmin 370
    Brieger, D
    Dawes, J
    [J]. THROMBOSIS AND HAEMOSTASIS, 1996, 75 (02) : 286 - 291
  • [10] Anti-Xa levels with low molecular weight heparin (Fraxiparin) and thrombolytic therapy for acute myocardial infarction
    deWinter, RJ
    Levi, M
    Chamuleau, SAJ
    Adams, R
    Buller, HR
    Prins, M
    Peters, RJG
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1168 - P1168
12345